+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pathogenic mechanism of retinopathy of prematurity: a controversial explanation for the efficacy of oral and intramuscular vitamin E supplementation and cryotherapy



Pathogenic mechanism of retinopathy of prematurity: a controversial explanation for the efficacy of oral and intramuscular vitamin E supplementation and cryotherapy



Bulletin of the new York Academy of Medicine 61(10): 883-900




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028865961

Download citation: RISBibTeXText

PMID: 3866628


Related references

Suppression of severe retinopathy of prematurity with vitamin E supplementation. Ultrastructural mechanism of clinical efficacy. Ophthalmology 91(12): 1512-1523, 1984

Operational aspects of terminating randomization in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Controlled Clinical Trials 12(2): 277-292, 1991

Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Archives of Ophthalmology 108(10): 1408-1416, 1990

Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Archives of Ophthalmology 111(3): 339-344, 1993

Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics 81(5): 697-706, 1988

Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Archives of Ophthalmology 108(2): 195-204, 1990

Vitamin E and retinopathy of prematurity: still controversial. Journal of Pediatrics 114(5): 801-803, 1989

Efficacy of cryotherapy for retinopathy of prematurity. Acta Ophthalmologica 70(3): 389-394, 1992

Efficacy of cryotherapy for acute retinopathy of prematurity. Early Human Development 21(2): 138, 1990

Visual acuity of eyes after vitrectomy for retinopathy of prematurity: follow-up at 5 1/2 years. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 103(4): 595-600, 1996

Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 105(7): 1292-1300, 1998

Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. Ophthalmology 103(9): 1432-1437, 1996

Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity. Archives of Ophthalmology 124(2): 199-202, 2006

15-year outcomes following threshold retinopathy of prematurity - Final results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Archives of Ophthalmology 123(3): 311-318, 2005

Outcome-based management of retinopathy of prematurity. Multicenter Trial of Cryotherapy for Retinopathy of prematurity Cooperative Group. Journal of Aapos 1(1): 46-54, 1997